Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial  (CAPNOR)

DiscussionWe will examine if rapid use of FAPplus panel in hospitalized patients with suspected CAP can improve both the time to and the proportion of patients receiving pathogen-directed treatment, thereby shortening the exposure to unnecessary antibiotics and the length of hospital admission, compared to the standard-of-care arm. The pragmatic design together with broad inclusion criteria and a straightforward intervention could make our results generalizable to other similar centres.Trial registrationClinicalTrials.govNCT04660084. Registered on December 9, 2020
Source: Trials - Category: Research Source Type: clinical trials